Pfizer CEO Albert Bourla said Tuesday that uncertainty surrounding President Donald Trump’s proposed pharmaceutical tariffs is discouraging the company from making additional investments in U.S. manufacturing and research, CNBC News reported April 29. Speaking to Pfizer’s first-quarter earnings, Mr. Bourla…
Pharmacy
Minnesota offers the highest hourly mean wage in the U.S. after adjusting for cost of living, while California has the highest unadjusted hourly mean wage, according to May 2024 salary data from the Bureau of Labor Statistics. Below are the…
The FDA has approved Zevaskyn, the first gene-modified cellular therapy for treating wounds in patients with recessive dystrophic epidermolysis bullosis, a rare genetic skin disorder. Made by Abeona Therapeutics, Zevaskyn consists of gene-corrected skin grafts made from the patients’ own…
The Iowa Senate has passed a bill that would set new requirements for pharmacy benefit managers that lawmakers say will help rural pharmacies stay open and lower prescription costs, the Iowa Capital Dispatch reported April 28. Here are four things…
Mark Cuban Cost Plus Drug Co. has secured another partnership targeting the specialty pharmaceutical market, according to an April 28 news release shared with Becker’s. EverPharm, a specialty unit-dose medication company, is joining its portfolio with Cost Plus Drugs’ pricing…
Advertisement
At Children’s Hospital of Philadelphia, an 11-year-old girl with severe beta thalassamia, became the first pediatric patient to receive Zyntelgo, the first FDA-approved gene therapy for transfusion-dependent beta thalassamia. Since receiving the therapy, the patient, Rahameen Nabeel, no longer requires…
Federal regulators have requested that Novavax conduct an additional randomized clinical trial of its COVID-19 vaccine, a costly demand that could threaten the company’s ability to comply, The Wall Street Journal reported April 25. The FDA asked the company to…
A proposed 25% tariff on U.S. pharmacy imports would drive up U.S. drug costs by $51 billion annually, according to an analysis by Ernst & Young reviewed by Reuters. The April 22 analysis, commissioned by the Pharmaceutical Research and Manufacturers…
A new report from the U.S. Senate Committee on Health, Education, Labor and Pensions, led by Chairman Bill Cassidy, is calling for reforms to the 340B drug pricing program following an investigation into how covered entities utilize program revenue. The…
A new study suggests the discontinuation of common asthma drug Flovent was linked to a higher rate of children halting inhaled steroid therapy altogether. In January 2024, a manufacturer stopped producing Flovent, an inhaled steroid commonly prescribed to prevent asthma…